Patients with essential tremor can have manual dexterity and attention deficits with no impairments in other cognitive functions by Inacio Medeiros, Leonardo Mariano et al.
122
DOI: 10.1590/0004-282X20160006
ARTICLE
Patients with essential tremor can have 
manual dexterity and attention deficits with 
no impairments in other cognitive functions
Pacientes com tremor essencial podem apresentar prejuízo na destreza manual e déficit 
de atenção sem prejuízo em outras áreas da cognição
Leonardo Mariano Inácio Medeiros1, Pollyanna Celso Felipe de Castro1, André C. Felício1,2, Bárbara Bernardo 
Queiros1, Sonia Maria Cesar Azevedo Silva1, Henrique Ballalai Ferraz1, Paulo Henrique Ferreira Bertolucci1, 
Vanderci Borges1
Essential tremor (ET) was long believed to be a monosymp-
tomatic disorder where tremor is the single clinical manifes-
tation1. However, new evidence has been produced in recent 
years, and it is now considered as a complex, heterogeneous 
disease characterized by a progressive course, that is possibly 
caused by different pathogenic mechanisms, with potential 
cognitive impairments2 suggesting non-motor compromise.
Several studies have shown that ET is associated with 
cognitive impairments. Lombardi et al. showed naming, 
short-term memory, working memory and verbal fluency def-
icits in 18 patients with ET3. Gasparini et al. evaluated fron-
tal lobe dysfunction in 27 patients with ET, 15 patients with 
Parkinson’s disease (PD) and 15 healthy controls and they 
found attention and verbal fluency deficits in the two former 
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AbstrACt
Essential tremor (ET) was long believed to be a monosymptomatic disorder. However, studies have evidenced structural changes and 
attention is now being focused on non-motor symptoms. The objective of the study is to describe and compare ET patients with control 
groups according to their cognitive functions, and secondarily, to compare their sociodemographic characteristics and other clinical 
features. All participants were assessed using the Fahn-Tolosa-Marin Tremor Rating Scale for the severity of tremor; a neuropsychological 
assessment battery and a screening questionnaire for mood and anxiety symptoms. There were no significant age and gender differences 
between all groups. As for neuropsychological assessment results, a significant difference was found only in the Pegboard test. We 
also found a significant negative correlation between a poorer cognitive test results and disease severity and a significant differences 
regarding depression or anxiety symptoms in patients with ET. The study results suggest that patients with ET have impaired manual 
dexterity and attention.
Keywords: essential tremor, cognition, anxiety, depression, manual dexterity.
resumo
O tremor essencial (TE) era considerado como um transtorno monossintomático. Contudo estudos tem demonstrado alterações 
anatômicas despertando o interesse para sintomas não-motores.O objetivo do estudo é descrever e comparar pacientes com grupos 
controles segundo suas funções cognitivas, e secundariamente, comparar suas características demográficas e outros sintomas clínicos. 
Todos os participantes foram submetidos à escala de Fahn, Tolosa e Marin para avaliação da intensidade do tremor, a uma bateria 
neuropsicológica e a um questionário para detecção de transtorno de humor e ansiedade. Não houve diferença significativa na idade 
e gênero entre todos os grupos. Quanto ao resultado da avaliação neuropsicológica, foi encontrado uma diferença significativa apenas 
no Test Pegboard. Nós também encontramos uma correlação negativa no desempenho dos testes cognitivos e intensidade do tremor, 
presença de sintomas depressivos e ansiosos. Os resultados deste trabalho sugerem que pacientes com TE apresentem alteração na 
destreza manual e na atenção.
Palavras-chave: tremor essencial, cognição, ansiedade, depressão, destreza manual.
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groups of patients compared to controls. Louis et al. recently 
demonstrated greater cognitive decline in patients with ET 
suggesting it is a potential risk factor for dementia4,5.
However, these studies3,4,5,6 have methodological limita-
tions, including small sample size with limited age range4,7, 
no comparison to a control group3,8, no control for comor-
bidities9, use of drugs that may affect cognition5, and other 
psychiatric disorders6.
Thus, in the light of the methodological limitations of previ-
ous studies and lack of studies assessing cognition in patients 
with ET in Brazil, we conducted a cross-sectional study to eval-
uate the neuropsychological performance and a screening for 
psychiatric symptoms in ET patients compared to two control 
groups of (related and unrelated) healthy individuals.
metHoD
Patient selection
We conducted the present study from November 2011 
to June 2013. We selected medical records of patients previ-
ously diagnosed with ET and followed up at our clinic (hav-
ing attended two or more visits). All patients were examined 
by at least two neurologists specialized in movement disor-
ders and their clinical diagnoses fulfilled the consensus crite-
ria for the diagnosis of ET10. Exclusion criteria included use 
of medications known to affect cognitive performance (ben-
zodiazepines, antidepressants, anticonvulsants, antihista-
mines, neuroleptics and hypnotics); prior diagnosis of mood 
or anxiety disorders; refusal to answer the questionnaire; and 
less than four years of schooling. All patients selected were 
able to answer the study questionnaire.
Clinical protocol
The initial strategy was to select cases matched by con-
trols at 3:1:1 ratio of three cases to one related and one 
unrelated control. First, we selected cases through random 
review of medical records and assessed them all. The patients 
were recruited by personal or phone invitation. Then we re-
cruited controls who underwent a clinical examination for 
ruling out any type of tremor or comorbidities that could pre-
vent their participation in the study. Related controls had to 
be first-degree relatives and they were recruited in order to 
try to detect pre motor symptoms.
 A priori selection of cases included 100 medical records 
before applying exclusion criteria.
We collected demographic information on the following 
variables: gender, age, comorbidities, level of education, mari-
tal status, use of medications and disease duration.
Demographic and clinical features
Of 100 randomly selected medical records, 44 patients 
with ET were included in the final sample. We excluded 56 
patients for different reasons (40% attended only one visit; 
30% had less than four years of schooling; 20% were diag-
nosed with mood disorders; and 10% were on psychotropic 
medication). After the inclusion of patients in the study, we 
actively recruited related and unrelated controls. We divid-
ed them into three groups: ET (n = 44); first-degree relatives 
without tremor (n = 20); and unrelated individuals without 
tremor (n = 39). We reached a ratio of approximately 2:1:2.
Demographic characteristics of the sample studied are 
presented in Table 1. There was a significantly greater pro-
portion of females among unrelated controls and of younger 
individuals among related controls.
Regarding comorbidities, there was no difference be-
tween patients with ET and related (p = 0.083) and unrelated 
controls (p = 0.110). Related controls had lower prevalence 
of heart diseases compared to unrelated controls (p = 0.005).
Tremor was assessed using the Fahn-Tolosa-Marin Tremor 
Rating Scale (TRS)11, translated into Portuguese and validat-
ed for the Brazilian population12. We calculated the total TRS 
Table 1. Distribution of cases and controls according to sociodemographic characteristics.
Variables
ET Unrelated controls Related controls
p-value
N (%) N (%) N (%)
Gender 0.046
Male 19 (43.2) 7 (18.0) 6 (30.0)
Female 2 (56.8)* 32 (82.0)* 14 (70.0)
Age (years) < 0.001
≤ 50 13 (29.5)** 5 (12.8)** 13 (65.0)**
> 50 31 (70.5) 34 (87.2) 7 (35.0)
Schooling (years) 0.159
4-8 13 (29.5) 10 (25.6) 2 (10.0)
9-11 15 (34.1) 12 (30.8) 4 (20.0)
12 or more 16 (36.4) 17 (43.6) 14 (70.0)
Marital status 0.933
Married 22 (50.0) 20 (51.3) 11 (55.0)
Single/divorced/widowed 22 (50.0) 19 (48.7) 9 (45.0)
Total 44 (100) 39 (100) 20 (100)
*Comparative difference between the groups in relation to gender; **Comparative difference between the groups in relation to age.
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score as follows: (Part A + Part B + Part C) / 156 x 100. The high-
er the final score (%) the more severe the patient’s condition.
All patients were assessed using the Montreal Cognitive 
Assessment (MoCA)13, validated for Brazilian population14, for 
global cognitive evaluation. In addition, the following neuropsy-
chological assessment battery was used: Pegboard test (manual 
dexterity, bimanual coordination and attention)15; Forward and 
Backward digit-span task (attention and immediate memory)16; 
Semantic Verbal fluency (semantic categories of animals and 
fruits) (executive function)17,18; Brown-Peterson task (short-term 
memory and attention)19,20; and the Frontal Assessment Battery 
(FAB) (Part 1) (abstraction and similarity)21.
We first compared cognitive test results among the three 
groups. Then we compared patients with ET older than 65 
with unrelated controls following the same methodological 
approach of prior studies3,4,6,22. We also used the cut-off of age 
65 to compare cognitive test results among patients with ET 
to check for any age-related changes.
We compared demographic characteristics and pres-
ence of depression and anxiety symptoms in all analyses. 
Comorbidities studied were heart, kidney, endocrine, infec-
tious and musculoskeletal conditions.
We also carried out a separate analysis including patients 
receiving or not primidone for the treatment of ET. Primidone 
is metabolized to phenobarbital that can cause somnolence 
and cognitive impairment as side effects23,24 and could affect 
the results.
The Hospital Anxiety and Depression Scale (HADS) was 
used to screen for depression and anxiety disorders.  A score 
of nine was set as cut-off for each subsection, HADS-Anxiety 
(HADS-A) and HADS-Depression (HADS-D), as suggested by 
Zigmond and Snaith25.
This study was approved by the local Research Ethics 
Committee (CEP/UNIFESP 5609/12). All participants signed 
an informed consent form.
statistical analysis
The Shapiro-Wilk test was used to test for the normality 
of the data and the independent two-tailed Student’s t-test to 
assess parametric data. Mann-Whitney test was performed 
to compare nonparametric data, the chi-square test to com-
pare frequencies, and Fisher’s exact test to analyze contin-
gency data. We conducted ANOVA with Bonferroni’s post 
hoc test for multiple comparisons or the Kruskal-Wallis test 
after non-normality of the data was verified in the Shapiro-
Wilk test. Data were presented as mean (m) ± standard de-
viation (SD) or as number of subjects (n) and percentage (%). 
The statistical significance was set at p ≤ 0.05.
resuLts
Analysis of cognitive aspects
The groups studied showed no statistically signifi-
cant differences in results of the MoCA  test (p = 0.653), 
Forward digit-span task (p = 0.056), Backward digit-span 
task (p = 0.074), Verbal fluency (semantic category of fruits) 
(p = 0.117) and Similarity test (p = 0.728) (Table 2).
A significant difference in mean scores of the three 
groups was found on the Brown-Peterson test (p = 0.029), 
Verbal fluency (semantic category of animals) (p = 0.041) 
and Pegboard test (right hand, left hand and both hands, 
p < 0.001). A significant difference in mean scores of the 
Brown-Peterson test was seen between patients with ET and 
related controls (p = 0.024). On the Pegboard test, patients 
with ET had lower scores compared to related and unrelated 
controls in all tasks. The findings are as follow: right hand 
test (p < 0.001 for patients versus unrelated controls and pa-
tients versus related controls; left hand test (p = 0.009 for pa-
tients versus unrelated controls and p = 0.001 for patients 
versus related controls); and both hands working together 
Table 2. Results of the cognitive tests obtained for patients with essential tremor (ET) versus related and unrelated controls (mean (SD)).
N
ET Unrelated controls Related controls
p-value
44 39 20
Cognitive tests
MoCA 25.8 (2.9) 25.8 (2.5) 25.6 (4.3) 0.653***
Forward digit-span task 5.3 (1.5) 4.9 (1.1) 5.7 (1.2) 0.056***
Backward digit-span task 4.0 (1.2) 4.0 (1.0) 4.7 (1.2)  0.074
Brown-Peterson task 6.3 (3.6) 7.3 (3.6) 9.0 (4.4)*  0.029
Pegboard test with right hand 10.9 (3.2) 13.5 (1.6)* 14.4 (2.7)* < 0.001****
Pegboard test with left hand 10.1 (2.8) 11.9 (2.8)* 12.9 (2.0)*  < 0.001
Pegboard test with both hands 17.2 (5.1) 20.6 (4.0)* 22.8 (5.6)* < 0.001***
Verbal fluency (animals) 18.2 (4.6) 18.1 (6.2) 21.2 (7.6)*  0.041***
Verbal fluency (fruits) 15.0 (3.8) 15.3 (3.9) 17.2 (4.4)  0.117
Similarity test  
0 or 1 2 (4.5%)  1 (2.6%)  1 (5.0%)  0.728** 
2 13 (29.6%) 17 (43.6%)  8 (40.0%)
3 29 (65.9%)  21 (53.8%)  11 (55.0%)  
MoCA: Montreal Cognitive Assessment; *Group with statistical significance compared to ET; **Chi-square test; ***Kruskal-Wallis test; ****Brown-Forsythe 
test correction. 
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(p = 0.007 for patients versus unrelated controls and p < 0.001 
for patients versus related controls).
 In the semantic category of animals of the Verbal fluency 
test, both patients with ET and unrelated controls showed 
lower scores than related controls (p = 0.030 and p = 0.015, 
respectively). This difference could be explained by lower age 
of the related controls.
A comparison of patients with unrelated controls older 
than 65 showed no significant differences with regard to gen-
der (p = 0.162), level of education (p = 0.803) and marital sta-
tus (p = 0.492). In addition, there was no difference regarding co-
morbidities and results of the following cognitive tests: MoCA 
(p = 0.789), Forward digit-span task (p = 0.356), Backward digit-
span task (p = 0.525), Brown-Peterson test (p = 0.188), Verbal flu-
ency (category of animals) (p = 0.073), Verbal fluency (category 
of fruits) (p = 0.892) and Similarity test (p = 0.262). However, pa-
tients with ET were older than controls (p = 0.049) and had low-
er mean scores on the Pegboard test with right hand (p < 0.001), 
left hand (p = 0.015) and both hands (p = 0.002). We made no 
comparisons between patients and related controls as the maxi-
mum age in this group was 64 years.
A comparison between younger and older than 65 ET pa-
tients showed higher mean scores on the Forward digit-span 
test (p = 0.033), Brown-Peterson test (p = 0.020), Pegboard 
test with right hand (p = 0.003), left hand (p < 0.001) and both 
hands (p = 0.001) among those aged up to 65.
We found no significant correlation between cognitive 
test results and disease duration (Table 3). However, we 
found a negative significant correlation between disease se-
verity and some cognitive test results (Table 3).
Table 4 shows cognitive test results according to the pres-
ence of depression and anxiety symptoms.
Finally, we found that patients with ET on primidone had 
lower mean scores on the MoCA (p = 0.021), Pegboard with right 
hand (p = 0.002), left hand (p < 0.001) and both hands (p = 0.002) 
when compared to patients without use of primidone.
DIsCussIoN
The results of this study suggest that patients with ET are 
more likely to have manual dexterity and attention deficits, 
with no differences compared to the control groups in cogni-
tive or other psychiatric functions assessed. In addition, pa-
tients with more severe disease showed poorer performance 
on cognitive tests. Another important finding of this study 
Table 3. Correlation coefficients between cognitive test results and duration or severity of essential tremor.
Cognitive tests
Disease duration Disease severity*
rS p-value rS p-value**
Moca  0.030 0.847 -0.346 0.022
Forward digit-span task -0.114 0.460 -0.341 0.024
Backward digit-span task -0.245 0.110 -0.357 0.017
Brown-peterson task -0.079 0.613 -0.421 0.005
Pegboard test with right hand  0.002 0.989 -0.419 0.005
Pegboard test with left hand -0.099 0.522 -0.461 0.002
Pegboard test with both hands -0.054 0.728 -0.502 < 0.001
Verbal fluency (animals) -0.020 0.899 -0.268 0.079
Verbal fluency (fruits)  0.052 0.738 -0.436 0.003
Similarity test  0.072 0.644  0.086 0.580
rS: Spearman’s correlation test; MoCA: Montreal Cognitive Assessment; *Disease severity according the total score of the Fahn-Tolosa-Marin Tremor Rating 
Scale; **p < 0.05. 
Table 4. Analysis of cognitive test results according to the presence or not of psychiatric comorbidity (mean ± standard deviation).
Cognitive tests
Anxiety Depression
 No (n = 29) Yes (n = 15) p-value* No (n = 35) Yes (n = 9) p-value*
MoCA 25.7 (2.9) 25.9 (3.0) 0.413 26.2 (2.8) 24.1 (2.8) 0.003**
Forward digit-span task 5.5 (1.5) 4.7 (1.4) 0.055** 5.5 (1.5) 4.3 (1.1) 0.003
Backward digit-span task 4.1 (1,4) 3.8 (0.9) 0.047** 4.1 (1.3) 3.8 (1.1) 0.179
Brown-Peterson task 6.2 (3.7) 6.4 (3.7) 0.929 6.7 (3.3) 4.4 (2.9) 0.035
Pegboard test with right hand 10.1 (3.1) 12.4 (2.8) 0.048 10.6 (3.1) 12.1 (3.3) 0.774
Pegboard test with left hand 9.4 (2.7) 11.4 (2.6) 0.168 9.8 (2.8) 11.1 (2.8) 0.750
Pegboard test with both hands 16.0 (5.0) 19.6 (4.7) 0.132 17.0 (5.1) 18.2 (5.2) 0.495
Verbal fluency (animals) 18.0 (4.3) 18.5 (4.3) 0.594 18.4 (4.7) 17.2 (3.9) 0.010
Verbal fluency (fruits) 14.8 (3.9) 15.3 (3.8) 0.997 15.5 (3.7) 13.2 (3.8) 0.012
Disease duration 20.0 (18.2) 26.2 (11.6) 0.037** 21.8 (17.6) 23.4 (11.3) 0.388**
Disease intensity 16.0 (8.7) 17.0 (7.1) 0.347** 15.6 (8.0) 19.8 (8.5) 0.167**
MoCA:Montreal Cognitive Assessment; *P < 0.05; **Mann Whitney test.
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was that patients with ET with depression and/or anxiety 
symptoms and those on use of primidone showed poorer 
manual dexterity and cognitive performance.
We decided to keep a control group of patients’ relatives 
trying to find pre motor subclinical change. This could sup-
port the hypothesis of a disease with greater range of symp-
toms but that was not the finding in our study.
A comparison between groups showed significant age 
and gender differences. This could be explained by the fact 
that unrelated controls were recruited through educational 
lectures attended by a greater proportion of females, which 
is in agreement to that described in the literature26. As for 
age, healthy controls had to attend a visit at the study site 
for testing, which made it difficult for older ones. In addi-
tion, many relatives of patients lived far from the study site 
and those who lived closer were their children. We found no 
statistical differences between ET patients and controls in 
results on the MoCA test, Verbal fluency (categories of ani-
mals and fruits) and Similarity test, but we found a difference 
in the Forward and Backward digit-span task. These results 
contrast with those reported in other studies3,6,7,9. One of the 
most important points of our study was to demonstrate that 
there was no difference in neuropsychological assessment in 
patients with ET compared with controls when controlled 
properly some biases.
The authors of the NEDICES study reported that patients 
with ET showed poorer verbal fluency in the semantic catego-
ry of fruits9; nevertheless, mean age of their patients was high-
er than that of the patients in our study (75 vs. 60 years, re-
spectively). Even after comparing only those over 65, we found 
no significant differences in verbal fluency. Furthermore, 
when we checked the cutoff point in the Verbal fluency test, 
semantic category of animals, for the Brazilian population27, 
we found that the mean score on the test was higher than the 
proposed one, demonstrating no loss of the cognitive function 
assessed. We saw significant differences only in test results of 
the Pegboard test and Brown-Peterson task.
We found manual dexterity and coordination deficits 
among patients with ET compared to controls in the Pegboard 
test. To our best knowledge, there is no study in the literature 
with patients with ET using the Pegboard test to assess man-
ual dexterity. We may assume these findings could be related 
not only to dexterity but also to attention deficits. Some stud-
ies assessing patients with ET showed they had poorer quality 
of life than healthy controls. The most affected domains were 
functional performance and physical limitation28,29, which 
may be explained by impaired manual dexterity. 
With regard to the Brown-Peterson task, patients with 
ET showed lower scores that were significantly different only 
when compared to scores in related controls. Related con-
trols had lower mean age, which may suggest that age may 
affect attention and working memory, as assessed in this 
test. This was verified when we compared patients and unre-
lated controls age 65 years or more: we found no significant 
difference in the Brown-Peterson task scores. Yet, this differ-
ence was evidenced once again when we compared patients 
with ET younger and older than 65. In a 2001 study, Gasparini 
et al. found executive function and attention deficits in pa-
tients with ET compared to controls suggestive of frontal 
lobe dysfunction6. The NEDICES study also showed abnor-
mal results in attention assessment tests9.
Kim et al. compared 34 patients with ET with 33 controls 
and found significant difference mainly in the Forward and 
Backward digit-span task and Verbal fluency test, but they 
did not assess depression and anxiety disorders, and use of 
medications that could affect cognitive performance22. Our 
study found a difference when we compared patients with 
ET younger and older than 65, indicating an overall deficit of 
attention with age.
Many studies evaluating cognitive aspects in patients 
with ET did not investigate the effects of depression and 
anxiety disorders and psychotropic medication use. In our 
study, we excluded patients on medications that may affect 
cognitive ability and those previously diagnosed with depres-
sion and anxiety disorders. Yet, we screened for depression 
and anxiety symptoms. A comparison between anxiety and 
non-anxiety patients showed altered results mainly in the 
Backward digit-span task that requires a high level of atten-
tion and in the Pegboard test with the right hand. Another 
interesting finding was a higher prevalence of anxiety found 
among patients with longer disease duration.
With regard to depression, we found lower scores on the 
MoCA test, Forward digit-span task, Brown-Peterson task 
and Verbal Fluency, in both categories of animals and fruits. 
Contrasting with Duane et al. findings, we found a lower fre-
quency of depression and anxiety symptoms in our study 
(20.5% vs. 55% of depression, and 34.1% vs. 49% of anxiety)30.
As for the use of medications that may affect cognitive 
ability, we included in the study only patients on use of primi-
done. A comparison of patients who were on primidone and 
those who were off primidone showed differences in the 
Pegboard test and the MoCA. Possibly this can be explained 
by a greater mean age of patients on primidone and its meta-
bolic effects24.
We did not find a correlation of cognitive test results 
with disease duration but we did find it with disease sever-
ity. Lombardi et al. and Troster et al. evaluated patients un-
responsive to medication requiring surgical treatment3,7, and 
they were found to have more severe disease, which could ex-
plain the abnormal results in cognitive assessment.
A number of important limitations of this study need 
to be considered. A major limitation was the use of a 
cross-sectional design as we were unable to assess time of 
onset and progression of cognitive symptoms in parallel to 
other features of ET. Our study was also limited by a great-
er proportion of females in the control group compared with 
cases. We also did not assess the correlation of ET with other 
areas of cognition ( for example, visuo-spatial function).
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Notwithstanding the aforementioned limitations, our 
study was able to show that patients with ET had manual 
dexterity and attention deficits with no impairments in other 
cognitive functions studied. In addition, patients with more 
severe disease showed poorer performance on cognitive 
tests. Cognitive symptoms and poor manual dexterity were 
more common among those with depression and anxiety 
symptoms as well as those taking primidone.
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